NCT02233907View on ClinicalTrials.gov

Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease

CompletedOBSERVATIONAL
Enrollment

595

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

August 31, 2001

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Ventilat® - metered dose inhaler

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02233907 - Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter